Home›Trial›NCT06523153
🔬NCT06523153Phase 1ACTIVE NOT RECRUITING

A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants

Study Summary

A study to investigate the safety, tolerability, and pharmacokinetics of a SARS-CoV-2-directed monoclonal antibody in healthy participants

Conditions
COVID-19
Interventions / Drugs
VYD2311Placebo
View on ClinicalTrials.gov ↗
Sponsor
IVVD
Invivyd Inc
Infectious Disease
D38/100
Study Details
Enrollment40 participants
Primary Completion—
Lead SponsorInvivyd, Inc.
Data Retrieved2026-04-11 04:18:15.922093+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.